Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
University of Cologne · German Center for Infection Research · +98 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,735
total citations
- FWCI
- 115.27
- Percentile
- 100%
- References
- 161
Citations per year
Authors
74- OAOliver A. CornelyCorresponding
University of Cologne, German Center for Infection Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne
- AAAna Alastruey‐Izquierdo
Instituto de Salud Carlos III
- DADorothee Arenz
University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne
- SCSharon C.‐A. Chen
The University of Sydney, Westmead Hospital
- ÉDÉric Dannaoui
Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou
Topics & keywords
Keywords
- Mucormycosis
- Guideline
- Posaconazole
- Medicine
- Disease
- Intervention (counseling)
- Intensive care medicine
- Amphotericin B
No related works found for this paper.
Funding
- PPfizer
- AAstraZeneca
- BBayer
- NNovartis
- RRoche
- 33M
- GSGilead Sciences
- TPTeva Pharmaceutical Industries
- MSMeso Scale Diagnostics
- CFChiesi Farmaceutici
- CLCharitable Leadership Foundation
- DZDeutsches Zentrum für Infektionsforschung
- MKMerck KGaA
- LLLes Laboratories Pierre Fabre
- PSPhysicians' Services Incorporated Foundation
- UOUniversity of Leeds
- ECEuropean Commission
- GAGlaxoSmithKline Australia
- BFBundesministerium für Bildung und Forschung
- CCovidien
- ASAgenzia Spaziale Italiana
- APAstellas Pharma
- DGDeutsche Gesellschaft für Epileptologie
- BPBasilea Pharmaceutica
- DZDeutsches Zentrum für Lungenforschung
- EREuropean Research Council